Clinical Presentation and Prognosis of SARS-CoV-2 Infection in Infants Aged ≤90 Days: Insights for Management During Outbreaks
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Infants aged ≤90 days with fever are susceptible to severe infections. This study aimed to analyze the clinical features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in this particular age group. Methods: Infants aged ≤90 days who were diagnosed with coronavirus disease 2019 (COVID-19) and hospitalized between March 1, 2020, and May 1, 2022 were included. Medical records of patients were retrospectively reviewed. Results: A total of 105 infants with COVID-19 were included; 27 (25.7%) neonates aged <28 days, and 48 (45.7%) and 30 (28.6%) infants aged 28–59 days and 60–90 days, respectively. Five (4.7%) patients remained asymptomatic and 68 (62.8%) were febrile, with a median fever duration of 2 days. The most common symptoms were respiratory including cough (66.6%), nasal stuffiness (51.4%), and rhinorrhea (40.9%). Blood cultures were performed in 10 infants but no organisms were detected. Cultures of bag-collected urine specimens from 8 infants were grown, resulting in positive growth for 2 without pyuria. Nine (8.6%) infants were treated with empirical antibiotics for a median duration of 2.3 days (range, 1–7 days). All 105 infants showed improvement without any complications, and there were no fatal cases. Conclusions: In this study, most infants aged ≤90 days with COVID-19 presented with mild symptoms and none of those evaluated had documented bacterial co-infection. The favorable prognosis among young infants with SARS-CoV-2 may aid clinicians in tailoring their approach to evaluation and management during outbreaks.
Abstract
Purpose: Infants aged ≤90 days with fever are susceptible to severe infections. This study aimed to analyze the clinical features of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in this particular age group. Methods: Infants aged ≤90 days who were diagnosed with coronavirus disease 2019 (COVID-19) and hospitalized between March 1, 2020, and May 1, 2022 were included. Medical records of patients were retrospectively reviewed. Results: A total of 105 infants with COVID-19 were included; 27 (25.7%) neonates aged <28 days, and 48 (45.7%) and 30 (28.6%) infants aged 28–59 days and 60–90 days, respectively. Five (4.7%) patients remained asymptomatic and 68 (62.8%) were febrile, with a median fever duration of 2 days. The most common symptoms were respiratory including cough (66.6%), nasal stuffiness (51.4%), and rhinorrhea (40.9%). Blood cultures were performed in 10 infants but no organisms were detected. Cultures of bag-collected urine specimens from 8 infants were grown, resulting in positive growth for 2 without pyuria. Nine (8.6%) infants were treated with empirical antibiotics for a median duration of 2.3 days (range, 1–7 days). All 105 infants showed improvement without any complications, and there were no fatal cases. Conclusions: In this study, most infants aged ≤90 days with COVID-19 presented with mild symptoms and none of those evaluated had documented bacterial co-infection. The favorable prognosis among young infants with SARS-CoV-2 may aid clinicians in tailoring their approach to evaluation and management during outbreaks.
참고문헌 (21)
- "The updates of COVID-19 in Republic of Korea" (2021)[URL]
- Long B, "Clinical update on COVID-19 for the emergency clinician : presentation and evaluation", Am J Emerg Med, 54, pp.46~57 (2022)
- Milcent K, "Use of procalcitonin assays to predict serious bacterial infection in young febrile infants", JAMA Pediatr, 170, pp.62~69 (2016)
- Brook I, "Unexplained fever in young children : how to manage severe bacterial infection", BMJ, 327, pp.1094~1097 (2003)
- Ralston S, "Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis : a systematic review", Arch Pediatr Adolesc Med, 165, pp.951~956 (2011)
- Pantell RH, "Evaluation and management of well-appearing febrile infants 8 to 60 days old", Pediatrics, 148, pp.e2021052228~ (2021)
- Han MS, "Clinical characteristics and viral RNA detection in children with coronavirus disease 2019 in the Republic of Korea", JAMA Pediatr, 175, pp.73~80 (2021)
- Trevisanuto D, "Coronavirus infection in neonates : a systematic review", Arch Dis Child Fetal Neonatal Ed, 106, pp.330~335 (2021)
- Castagnoli R, "Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection in children and adolescents : a systematic review", JAMA Pediatr, 174, pp.882~889 (2020)
- Cui X, "Children with coronavirus disease 2019 : a review of demographic, clinical, laboratory, and imaging features in pediatric patients", J Med Virol, 92, pp.1501~1510 (2020)
- Payson A, "Risk of serious bacterial infections in young febrile infants with COVID-19", Pediatr Emerg Care, 37, pp.232~236 (2021)
- Güngör A, "COVID-19 infection in well-appearing 30-to 90-day-old infants with fever without a source", J Trop Pediatr, 68, pp.fmac046~ (2022)
- Guernsey D 3rd, "COVID-19 and serious bacterial infection in febrile infants less than 60 days old", West J Emerg Med, 23, pp.754~759 (2022)
- Leibowitz J, "Comparison of clinical and epidemiologic characteristics of young febrile infants with and without severe acute respiratory syndrome coronavirus-2 infection", J Pediatr, 229, pp.41~47.e1 (2021)[DOI]
- Mithal LB, "SARS-CoV-2 infection in infants less than 90 days old", J Pediatr, 224, pp.150~152 (2020)
- McLaren SH, "Novel coronavirus infection in febrile infants aged 60 days and younger", Pediatrics, 146, pp.e20201550~ (2020)
- Burstein B, "Urinary tract infection, bacteremia, and meningitis among febrile young infants with SARS-CoV-2 and non-SARS-CoV-2 viral infections", JAMA Netw Open, 6, pp.e2321459~ (2023)
- Burstein B, "Prevalence of serious bacterial infections among febrile infants 90 days or younger in a Canadian urban pediatric emergency department during the COVID-19 pandemic", JAMA Netw Open, 4, pp.e2116919~ (2021)
- Zeng L, "Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China", JAMA Pediatr, 174, pp.722~725 (2020)
- Böncüoğlu E, "Do not miss the diagnosis of bacterial sepsis in infants with COVID-19", Pediatr Infect Dis J, 41, pp.e31~e32 (2022)
- Blázquez-Gamero D, "Fever without source as the first manifestation of SARS-CoV-2 infection in infants less than 90 days old", Eur J Pediatr, 180, pp.2099~2106 (2021)